On the recordFebruary 26, 2014
Our share, U.S. share, of biomedical R&D expenditure declined from 52 percent to 42 percent despite what is happening in the rest of the world.
Source
congress.govOur share, U.S. share, of biomedical R&D expenditure declined from 52 percent to 42 percent despite what is happening in the rest of the world.
DeLauro highlights the decline in U.S. biomedical R&D funding compared to global trends.
Share
More from Rosa DeLauro
The Senate bill text is a clear improvement over the House Republican continuing resolution.
“I want to reestablish the COVID-era Expanded Child Tax Credit, which supporters say lifted millions out of poverty.”
These funds were provided for lifesaving medical research, not as extra money for the Department of Defense.
This $10 million federal investment will make a drastic difference in the lives of young people, ensuring that they have the science-backed tools needed to read proficiently.